{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:17:02Z","timestamp":1740115022293,"version":"3.37.3"},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2007991"],"award-info":[{"award-number":["GNT2007991"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["104999","106035"],"award-info":[{"award-number":["104999","106035"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.tcm.2024.01.006","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T16:45:20Z","timestamp":1706287520000},"page":"451-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial commentary: Oral anticoagulation for hemodialysis patients with atrial fibrillation: The therapeutic conundrum remains"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6883-0703","authenticated-orcid":false,"given":"John D","family":"Horowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha M","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2024.01.006_bib0001","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-147-8-200710160-00018","article-title":"Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation","volume":"147","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tcm.2024.01.006_bib0002","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/CRD.0000000000000312","article-title":"Direct-acting oral anticoagulants in atrial fibrillation: what's new in the literature?","volume":"29","author":"Ferrari","year":"2021","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.tcm.2024.01.006_bib0003","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2024.01.006_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/346752","article-title":"Anticoagulation for prosthetic valves","volume":"2013","author":"Kaneko","year":"2013","journal-title":"Thrombosis"},{"key":"10.1016\/j.tcm.2024.01.006_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/rth2.12083","article-title":"Safety and effectiveness of apixaban compared to warfarin in dialysis patients","volume":"2","author":"Reed","year":"2018","journal-title":"Res Pract Thromb Hemostas"},{"key":"10.1016\/j.tcm.2024.01.006_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcm.2023.11.005","article-title":"Oral anticoagulants in patients on chronic hemodialysis: contemporary appraisal on the role for patients with atrial fibrillation","author":"Niehues","year":"2024","journal-title":"Trend Cardiovasc Med"},{"key":"10.1016\/j.tcm.2024.01.006_bib0007","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s40620-022-01413-x","article-title":"A systemic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease","volume":"35","author":"Parker","year":"2022","journal-title":"J Nephrol"},{"key":"10.1016\/j.tcm.2024.01.006_bib0008","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2018.05.058","article-title":"Asymmetric and symmetric dimethylarginine predict outcomes in patients with atrial fibrillation","volume":"72","author":"Horowitz","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2024.01.006_bib0009","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2017.03.053","article-title":"The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease","volume":"92","author":"Tomlinson","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.tcm.2024.01.006_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13318-018-0501-y","article-title":"Clinical pharmacokinetics and pharmacodynamics of direct oral anticoagulants in patients with renal failure","volume":"44","author":"Padrini","year":"2019","journal-title":"Eur J Drug Metab"},{"key":"10.1016\/j.tcm.2024.01.006_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/CRD.0000000000000624","article-title":"Factor XI\/Xia inhibitors: a new approach to anticoagulation","author":"Whiteson","year":"2023","journal-title":"Cardiol Rev"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173824000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173824000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T23:04:08Z","timestamp":1726355048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173824000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1050173824000069"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2024.01.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"type":"print","value":"1050-1738"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial commentary: Oral anticoagulation for hemodialysis patients with atrial fibrillation: The therapeutic conundrum remains","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2024.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}